Novel Prion Protein Gene (PRNP) Variants in Wild Montana Mule Deer

This study identifies 36 novel and known PRNP genetic variants in 358 wild Montana mule deer, utilizing computational modeling and RT-QuIC assays to elucidate how specific mutations like V12F and S225F influence protein structure and potentially affect susceptibility to Chronic Wasting Disease.

The Gist

Imagine a forest where the deer, elk, and moose are the main characters. For decades, a mysterious, fatal sickness called Chronic Wasting Disease (CWD) has been creeping through these herds. Think of CWD as a "glitch" in the deer's biological software. Normally, their bodies have a helpful protein (let's call it the "Good Guy") that does its job and stays healthy. But in CWD, this protein gets corrupted, turns into a "Bad Guy" (a misfolded prion), and starts forcing all the other Good Guys to turn into Bad Guys. Eventually, the deer's brain turns into a sponge, and they waste away.

This paper is like a detective story where scientists went out into the wilds of Montana to look at the "source code" (the DNA) of 358 mule deer to see if they could find any clues that might explain why some deer get sick and others don't.

Here is the breakdown of their investigation, explained simply:

1. The Genetic "Typo" Hunt

Every deer has a gene called PRNP that acts as the blueprint for building that "Good Guy" protein. Sometimes, nature makes a tiny typo in this blueprint.

• The Discovery: The scientists found 36 different typos (variants) in the deer DNA. Many of these were brand new discoveries that no one had seen in mule deer before.
• The Analogy: Imagine a recipe for a cake. Most recipes are the same, but some have a tiny change: maybe a pinch of salt instead of sugar, or baking soda instead of baking powder. Some of these changes make the cake taste weird, some make it taste better, and some might make it explode. The scientists found many new "ingredients" in the deer population.

2. The "Good" and "Bad" Typos

The team looked closely at four specific typos to see what they did:

• The "Super-Resistant" Typo (S225F):

  • What it is: This is a known typo where the deer has a "phenylalanine" instead of "serine" at position 225.
  • The Result: Think of this as a reinforced steel door. The computer models showed that this change makes the protein so stable that the "Bad Guy" prions can't easily break it down or turn it into a zombie. It's like the protein is wearing armor.
  • The Catch: It's very rare in Montana right now.

• The "Suspicious" Typos (V12F, D20G, R40Q):

  • What they are: These are changes near the "start button" of the protein (the signal peptide).
  • The Result:
    • V12F: This one was found in deer that were sick. The scientists think this change might be like a broken delivery truck. It messes up how the protein gets to the right place in the cell, making it easier for the "Bad Guy" to take over.
    • D20G: This was the most common typo. It seemed to be neutral—like a paint color change on a car. It didn't seem to make the deer significantly more or less likely to get sick.
    • R40Q: This was found in deer that tested negative for CWD on standard tests, but when the scientists used a super-sensitive test, they found a tiny bit of the "Bad Guy" prion. This suggests this typo might be a smoke alarm that goes off very early, catching the disease before the standard tests can see it.

3. The "Super-Sensitive" Test (RT-QuIC)

Usually, doctors test for CWD by looking for the "Bad Guy" protein in the deer's lymph nodes. But sometimes, the standard test misses it if there's only a tiny amount.

• The Analogy: Imagine trying to hear a whisper in a noisy room. The standard test (ELISA) is like a regular microphone; it might miss the whisper. The new test (RT-QuIC) is like a high-tech parabolic dish that can amplify that whisper until it's loud and clear.
• The Finding: Using this super-sensitive test, the scientists found that even some deer that looked "healthy" (negative on standard tests) actually had a tiny bit of the disease-causing protein. This is huge because it means the disease might be spreading more quietly than we thought.

4. The Big Picture: Why Does This Matter?

The scientists wanted to know: If CWD is spreading, are the deer evolving to fight back?

• The Surprise: They expected to see that in areas with lots of sick deer, the "Good Armor" typos (like S225F) would be common because the sick deer would die off, leaving only the resistant ones.
• The Reality: They didn't see that yet. The "Good Armor" is still very rare. Instead, they found that the disease is spreading so fast that the deer haven't had time to evolve a defense yet.
• The Warning: They also found that some of these new typos might actually make the disease worse or help it spread in new ways.

The Takeaway

This paper is a warning and a roadmap.

1. The Enemy is Adapting: CWD is spreading fast, and the deer are still mostly vulnerable.
2. We Need Better Tools: The standard tests might be missing early cases. We need the "super-sensitive" tests to catch the disease sooner.
3. Genetics is Key: By understanding these tiny DNA typos, we might eventually be able to breed deer that are naturally resistant to the disease (like we did with sheep and scrapie in the past) or manage the wild herds better to stop the spread.

In short: The scientists found new "glitches" in the deer's code. Some glitches might protect them, but most seem to be neutral or even helpful to the disease. The race is on to understand these glitches before the disease becomes unstoppable.

Technical Summary

1. Problem Statement

Chronic Wasting Disease (CWD) is a fatal, transmissible spongiform encephalopathy (TSE) affecting cervids (deer, elk, moose). It is expanding geographically and increasing in prevalence, posing ecological risks and potential zoonotic threats. While polymorphisms in the prion protein gene (PRNP) are known to influence susceptibility and disease progression in some species (e.g., the 225F variant in mule deer), the full spectrum of genetic variation in wild Montana mule deer populations remains poorly characterized. Specifically, the structural and functional consequences of novel PRNP variants on protein stability, misfolding, and prion seeding activity are largely unknown. Understanding these variants is critical for predicting disease trajectories, managing wildlife populations, and assessing species barriers.

2. Methodology

The study employed a multi-faceted approach combining field sampling, genomic sequencing, computational modeling, and in vitro prion detection assays.

• Sample Collection & Sequencing:
  • Source: 358 retropharyngeal lymph node samples from wild mule deer (Odocoileus hemionus) collected across six Montana hunting districts during the 2017, 2018, and 2022 hunting seasons.
  • CWD Status: Samples were pre-screened via ELISA and confirmed via immunohistochemistry (IHC).
  • Genomics: DNA was extracted, and the PRNP coding region was amplified via PCR and sequenced using Sanger sequencing. Variants were identified by aligning against the wild-type GenBank accession AY228473.1.
• Spatiotemporal Analysis:
  • Variant prevalence was mapped against hunting districts and harvest years to identify trends in distribution and potential selection pressures.
• Computational Structural Modeling (EmCAST):
  • The EmCAST (empirical Cα stabilization) software was used to predict the structural and stability effects of specific non-synonymous variants (V12F, D20G, R40Q, S225F).
  • Models focused on the N-terminal unstructured region (residues 1–44) and the folded/fibril states of the protein to assess stability changes (ΔΔG) and conformational compatibility.
• Prion Seeding Assay (RT-QuIC):
  • Substrate: Recombinant Bank vole prion protein (rPrP), known for universal susceptibility to various prion strains.
  • Process: Lymph node homogenates (10⁻³ dilution) were incubated with rPrP substrate in a Real-Time Quaking-Induced Conversion (RT-QuIC) assay.
  • Readout: Thioflavin T (ThT) fluorescence was monitored to detect amyloid formation (prion seeding activity).
  • Controls: Included CWD-positive/negative transgenic mouse brains (Tg1536+/+), wild-type mule deer brain/lymph nodes, and PRNP knockout mice.

3. Key Contributions

• Discovery of Novel Variants: Identified 36 total PRNP polymorphisms in Montana mule deer, including 25 non-synonymous and 11 synonymous variants. Many of these (e.g., V12F, R40Q) had not been previously reported in mule deer.
• Structural Prediction of Novel Mutations: Provided the first computational structural analysis of novel variants (V12F, D20G, R40Q) using EmCAST, linking sequence changes to potential stability and conformational shifts.
• Functional Validation: Demonstrated that CWD-positive samples harboring novel variants (specifically V12F) possess prion seeding activity detectable by RT-QuIC, confirming the presence of infectious prions despite the genetic variation.
• Discrepancy Detection: Identified cases where RT-QuIC detected seeding activity in samples previously classified as CWD-negative by ELISA, suggesting RT-QuIC may offer higher sensitivity for early-stage or low-titer infections in lymph nodes.

4. Key Results

A. Genetic Diversity and Distribution

• Prevalence: 15.1% of samples contained non-synonymous variants. Multiple polymorphisms within a single individual were common (found in 9 deer).
• Spatiotemporal Trends: Variant prevalence varied significantly by district and year. For instance, Hunting District 401 saw a jump from 6.5% (early period) to 43.3% (late period) in variant prevalence, while District 555 decreased.
• CWD Correlation: While statistical correlation was limited by sample size, specific patterns emerged:
  • V12F: All samples with this novel variant were CWD-positive.
  • S225F: Consistent with literature, this variant was rare and associated with CWD-negative status (suggesting protection).
  • R40Q: Found in CWD-negative samples by ELISA but showed positive seeding activity in RT-QuIC.

B. Computational Modeling (EmCAST)

• V12F: Predicted to be slightly stabilizing (+0.114 kcal/mol) but located in the hydrophobic signaling peptide. The authors hypothesize the phenotype is driven by altered protein-protein interactions or trafficking rather than global stability.
• D20G: Predicted to introduce a kink in the N-terminal helix (-0.725 kcal/mol), potentially disrupting the helical structure.
• R40Q: Located in a disordered loop; predicted to have minor structural perturbations but removes a charged residue, potentially affecting aggregation propensity.
• S225F: Predicted to be neutral for folded PrP but incompatible with fibril PrP structures, supporting the hypothesis that this variant protects against CWD by preventing fibril formation.

C. RT-QuIC Seeding Activity

• Positive Confirmation: All CWD-positive samples (wild-type and variant carriers like V12F, V12I, D20G) showed significant ThT fluorescence, confirming prion seeding.
• Novel Variant Activity: Samples with the novel V12F variant demonstrated robust seeding activity, proving that this mutation does not prevent prion propagation.
• False Negatives in ELISA: Two samples classified as CWD-negative by ELISA (one Wild-Type, one R40Q variant) tested positive in RT-QuIC. This suggests RT-QuIC may detect early-stage infection or lower prion loads that ELISA misses.

5. Significance

• Genetic Surveillance: This study establishes a baseline for PRNP diversity in Montana, revealing that novel variants are more common than previously thought and can co-occur within single individuals.
• Mechanistic Insight: The findings suggest that variants in the N-terminal signaling peptide (e.g., V12F, D20G) can influence CWD susceptibility and prion propagation, challenging the view that only the globular domain dictates disease outcomes.
• Diagnostic Implications: The detection of seeding activity in ELISA-negative samples highlights the superior sensitivity of RT-QuIC for surveillance, particularly in lymph nodes where prion loads may be lower than in brain tissue.
• Management & Evolution: The presence of CWD-positive animals with novel variants indicates that these mutations do not necessarily confer resistance. Conversely, the rarity of the protective S225F variant in this dataset suggests that natural selection for resistance has not yet significantly altered the population genetics in these specific Montana districts, likely due to the relatively recent introduction of CWD to the area.
• Zoonotic Potential: By characterizing how novel mutations affect prion strain properties and seeding efficiency, the study contributes to understanding the potential for CWD to adapt to new hosts, including humans.

In conclusion, this research bridges the gap between genetic variation and functional prion biology in wild mule deer, providing critical data for future disease modeling, management strategies, and risk assessment.